This video is sponsored by Sanofi and Regeneron. Tan France helps fitness guru Arsalan unpack his severe eczema story and celebrate his Now Me moment. After years of struggling with uncontrolled severe eczema, or atopic dermatitis, Arsalan decided to take his treatment into his own hands and ask his doctor about another treatment option.
Watch his full story about living with severe eczema and his journey with Dupixent®, or dupilumab, a prescription medicine for people 6 years and older with uncontrolled moderate-to-severe eczema. And, discover the full series as part of The Now Me Program in partnership with Sanofi and Regeneron.
INDICATION
DUPIXENT is a prescription medicine used to treat people aged 6 years and older with moderate-to-severe atopic dermatitis (eczema) that is not well controlled with prescription therapies used on the skin (topical), or who cannot use topical therapies. DUPIXENT can be used with or without topical corticosteroids. It is not known if DUPIXENT is safe and effective in children with atopic dermatitis under 6 years of age.
IMPORTANT SAFETY INFORMATION
DO NOT USE if you are allergic to dupilumab or to any of the ingredients in DUPIXENT®.
BEFORE USING DUPIXENT, TELL YOUR HEALTHCARE PROVIDER ABOUT ALL YOUR MEDICAL CONDITIONS, INCLUDING IF YOU:
- have eye problems
- have a parasitic (helminth) infection
- are scheduled to receive any vaccinations. You should not receive a “live vaccine” if you are treated with DUPIXENT.
- are pregnant or plan to become pregnant. It is not known whether DUPIXENT will harm your unborn baby. There is a pregnancy exposure registry for women who take DUPIXENT during pregnancy to collect information about the health of you and your baby. Your healthcare provider can enroll you or you may enroll yourself. To get more information about the registry call 1-877-311-8972 or go to https://mothertobaby.org/ongoing-study/dupixent/
- are breastfeeding or plan to breastfeed. It is not known whether DUPIXENT passes into your breast milk.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins and herbal supplements.
Especially tell your healthcare provider if you are taking oral, topical, or inhaled corticosteroid medicines or if you have atopic dermatitis and asthma and use an asthma medicine. DO NOT change or stop your corticosteroid medicine or other asthma medicine without talking to your healthcare provider. This may cause other symptoms that were controlled by the corticosteroid medicine or other asthma medicine to come back.
DUPIXENT CAN CAUSE SERIOUS SIDE EFFECTS, INCLUDING:
- ALLERGIC REACTIONS (HYPERSENSITIVITY), INCLUDING A SEVERE REACTION KNOWN AS ANAPHYLAXIS. Stop using DUPIXENT and tell your healthcare provider or get emergency help right away if you get any of the following symptoms: breathing problems, fever, general ill feeling, swollen lymph nodes, swelling of the face, mouth and tongue, hives, itching, fainting, dizziness, feeling lightheaded (low blood pressure), joint pain, or skin rash.
- EYE PROBLEMS. Tell your healthcare provider if you have any new or worsening eye problems, including eye pain or changes in vision.
THE MOST COMMON SIDE EFFECTS IN PATIENTS WITH ATOPIC DERMATITIS INCLUDE injection site reactions, eye and eyelid inflammation, including redness, swelling, and itching, and cold sores in your mouth or on your lips.
Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of DUPIXENT. Call your doctor for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit https://www.fda.gov/medwatch, or call 1-800-FDA-1088.
Use DUPIXENT exactly as prescribed. Your healthcare provider will tell you how much DUPIXENT to inject and how often to inject it. DUPIXENT is an injection given under the skin (subcutaneous injection). If your healthcare provider decides that you or a caregiver can give DUPIXENT injections, you or your caregiver should receive training on the right way to prepare and inject DUPIXENT. DO NOT try to inject DUPIXENT until you have been shown the right way by your healthcare provider. In children 12 years of age and older, it is recommended that DUPIXENT be administered by or under supervision of an adult. In children younger than 12 years of age, DUPIXENT should be given by a caregiver.
Full Prescribing Information: https://bit.ly/DupixentPI
Patient Information: https://bit.ly/3e429aW
Learn more about DUPIXENT at https://www.dupixent.com
DUP.21.04.0274
0 Comments